Influx Healthtech
IPO Timeline
Issue open date
18 Jun 2025Issue close date
20 Jun 2025UPI mandate deadline
20 Jun 2025Allotment finalization
23 Jun 2025Refund initiation
24 Jun 2025Share credit
24 Jun 2025Listing date
25 Jun 2025Mandate end date
5 Jul 2025Lock-in end date for anchor investors (50%)
23 Jul 2025Lock-in end date for anchor investors (remaining)
21 Sep 2025Grey Market Premium Trend
GMP History
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 24 Jun | ₹22 | ₹118 | 22.92% |
| 23 Jun | ₹22 | ₹118 | 22.92% |
| 21 Jun | ₹38 | ₹134 | 39.58% |
| 20 Jun | ₹38 | ₹134 | 39.58% |
| 19 Jun | ₹45 | ₹141 | 46.88% |
| 18 Jun | ₹40 | ₹136 | 41.67% |
| 17 Jun | ₹35 | ₹131 | 36.46% |
| 16 Jun | ₹22 | ₹118 | 22.92% |
| 14 Jun | ₹24 | ₹120 | 25.00% |
| 13 Jun | ₹16 | ₹112 | 16.67% |
| 12 Jun | ₹0 | ₹96 | 0.00% |
About the Company
Influx Healthtech is a Mumbai-based healthcare company specializing in contract development and manufacturing services (CDMO). Established in 2020, the company operates multiple manufacturing facilities in Thane, Maharashtra, with a combined area of over 36,000 square feet. These facilities hold certifications including GMP, HACCP, ISO 22000, and Halal, ensuring compliance with international quality and safety standards. Influx Healthtech offers manufacturing expertise across a broad range of products such as dietary and nutritional supplements, cosmetics, ayurvedic and herbal products, veterinary feed supplements, homecare products, active pharmaceutical ingredients (APIs), and finished dosage forms including tablets, capsules, and injectables.
Strengths
- Diversified portfolio across nutraceuticals, Ayurveda, and wellness products reduces sector-specific risks.
- Rigorous QA/QC processes, global certifications (ISO, FDA), and adherence to food safety standards ensure consistent high product quality.
- Formulation team develops safe, stable, and custom nutraceutical, cosmetic, and veterinary products for clients.
Risks
No risks provided as of now. Please check back later.